sitagliptin metformin tablets

Sitagliptin Metformin Tablets are an oral drug that combines sitagliptin and metformin and is mainly used to treat type 2 diabetes. This fixed-dose combination is designed to work synergistically between the two ingredients to help patients better manage their blood sugar levels.

Sitagliptin belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. Its mechanism of action is to slow down the decomposition rate of insulin by inhibiting the activity of DPP-4 enzyme, thereby increasing the concentration of insulin in the body. Insulin is a hormone that lowers blood sugar levels and regulates blood sugar by prompting cells to take up and use glucose.

Metformin, meanwhile, is an ancient and effective oral hypoglycemic drug that belongs to the biguanide class of drugs. Its main action is to lower blood sugar levels by slowing the release of glucose from the liver, increasing tissue sensitivity to glucose, and delaying the absorption of carbohydrates from the gastrointestinal tract.

The combined use of sitagliptin and metformin has several advantages. First, the mechanism of action of metformin is different from that of sitagliptin, and the two have complementary effects in regulating blood sugar. Secondly, combined medication alleviates patients’ convenience issues associated with using two different medications and improves patient compliance.

During the use of sitagliptin metformin tablets, patients need to follow the doctor’s recommendations. The dosage and frequency of use of the drug will be individualized based on the patient's specific condition. In addition, patients should also receive regular medical monitoring, including measurement of blood sugar levels and other relevant biochemical indicators, to ensure the efficacy and safety of the drug.